SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : JMAR Technologies(JMAR) -- Ignore unavailable to you. Want to Upgrade?

To: henry jakala who wrote (4509)12/17/1997 6:42:00 PM
From: Bilberry  Respond to of 9695
 
Henry, to respond to several of your remarks, first off, if you do a private placement you cannot prevent shorting. So whether it is Swiss or Swiss Miss, it really does not matter. This was a short-term event that raised money for JMAR. A buying opportunity. This will not change the long-term successes of JMAR.

Secondly, it is far easier to apply to the FDA if you are not the first to introduce a device. JMAR will not be the first to get FDA approval for its Light Knife, so it should be far easier to get its application through as a similar device. (Through BD of course).

--Bilberry



To: henry jakala who wrote (4509)12/17/1997 7:09:00 PM
From: Dave Swanson  Read Replies (1) | Respond to of 9695
 
Regarding FDA application-- I seem to recall that the Lite-Knife is in
"final stages of development". I wouldn't expect application to FDA
until development is complete.
They might not expect difficulty with FDA approval, but I bet it
will take a while, even without difficulties.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News